Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 101–200 of 1,000
Fui, L. W., Lok, M. P. W., Govindasamy, V., Yong, T. K., Then, K., & Das, A. K. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2966 · Cited by 100
Mesenchymal stem cell–derived small extracellular vesicles and bone regeneration
Wang, X., & Thomsen, P. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13478 · Cited by 97
Drobiova, H., Sindhu, S. T. A. K., Ahmad, R., Haddad, D., Al‐Mulla, F., & Madhoun, A. S. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1211217 · Cited by 108
“As mentioned above, the secretome is composed of soluble factors (growth factors, cytokines, chemokines, interleukins, prostaglandins, angiogenic mediators, hormones) and EVs including exosomes and MVs that harbor the vital molecules including lipids, proteins (cell adhesion molecules, extracellular matrix proteins, r…”
BackgroundMesenchymal stem cell-based therapy for burn wound healing
Wang, M., Xu, X., Lei, X., Tan, J., & Xie, H. (2021) · Burns & Trauma · doi:10.1093/burnst/tkab002 · Cited by 100
“However, some studies have shown that implanted cells cannot survive long-term [101].”
BackgroundZhang, C., Huang, Y. L., Ouyang, F., Su, M., Li, W., Chen, J., Xiao, H., Zhou, X., & Liu, B. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02445-7 · Cited by 92
“Nowadays it is generally accepted that the therapeutic efficacy of MSCs is mainly attributed to their paracrine factors rather than cell differentiation and replacement of damaged cells [21, 22].”
BackgroundFigliolini, F., Ranghino, A., Grange, C., Cedrino, M., Tapparo, M., Cavallari, C., Rossi, A., Togliatto, G., Femminò, S., Gugliuzza, M. V., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313506 · Cited by 86
The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells
Liu, J., Liu, Q., & Chen, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01843 · Cited by 94
Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents
Abbasi‐Malati, Z., Roushandeh, A. M., Kuwahara, Y., & Roudkenar, M. H. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9817-x · Cited by 88
Yahao, G., & Xinjia, W. (2021) · Cell Transplantation · doi:10.1177/09636897211057465 · Cited by 83
Tan, S. S. H., Tjio, C. K. E., Wong, J. R. Y., Wong, K. L., Chew, J. R. J., Hui, J. H. P., & Toh, W. S. (2021) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0326 · Cited by 83
dos Santos, C. C., Amatullah, H., Vaswani, C. M., Maron‐Gutierrez, T., Kim, M., Mei, S. H. J., Szászi, K., Monteiro, A. P. T., Varkouhi, A. K., Herreroz, R., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04216-2020 · Cited by 89
Biotherapeutic Effect of Gingival Stem Cells Conditioned Medium in Bone Tissue Restoration
Diomede, F., Gugliandolo, A., Scionti, D., Merciaro, I., Cavalcanti, M. F. X. B., Mazzon, E., & Trubiani, O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020329 · Cited by 88
“It is known that MSCs release different factors, including growth factors, soluble proteins, free nucleic acids, also called the secretome of MSCs [17].”
BackgroundDong, L., Li, L., Song, Y., Fang, Y., Liu, J., Chen, P., Wang, S., Wang, C., Xia, T., Liu, W., et al. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.035 · Cited by 80
Laggner, M., Gugerell, A., Bachmann, C., Hofbauer, H., Vorstandlechner, V., Seibold, M., Gouya Lechner, G., Peterbauer, A., Madlener, S., Demyanets, S., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1524-2 · Cited by 76
Taei, A. A., Nasoohi, S., Hassanzadeh, G., Kadivar, M., Dargahi, L., & Farahmandfar, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111709 · Cited by 86
Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
da Costa, V. R., Araldi, R. P., Vigerelli, H., D’Ámelio, F., Mendes, T. B., Gonzaga, V. F., Policiquio, B. D. O., Colozza‐Gama, G. A., Valverde, C. W., & Kerkis, I. (2021) · Cells · doi:10.3390/cells10102617 · Cited by 86
Dental Pulp Stem Cells Derived From Adult Human Third Molar Tooth: A Brief Review
Madhoun, A. S. A., Sindhu, S. T. A. K., Haddad, D., Atari, M., Ahmad, R., & Al‐Mulla, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.717624 · Cited by 88
Colombini, A., Orfei, C. P., Kouroupis, D., Ragni, E., Luca, P. D., Viganò, M., Correa, D., & de Girolamo, L. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.10.004 · Cited by 84
Current advances in stem cell-based therapies for hair regeneration
Yuan, A., Bian, Q., & Gao, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173197 · Cited by 81
Wangler, S., Kamali, A., Wapp, C., Wuertz‐Kozak, K., Häckel, S., Fortes, C., Benneker, L. M., Haglund, L., Richards, R. G., Alini, M., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02062-2 · Cited by 88
“The secretome composition is influenced by the environment which the MSCs are exposed to [17, 18, 22].”
BackgroundMunoz-Perez, E., Gonzalez‐Pujana, A., Igartúa, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111802 · Cited by 85
Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
Yin, Q., Ji, X., Lv, R., Pei, J.-J., Du, Y., Shen, C., & Hou, X. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s240400 · Cited by 77
“Thus, it may be possible to use MSC-derived exosomes as a cell-free therapy for the treatment of AD.(109)”
BackgroundCouto, P. S., Rotondi, M. C., Bersenev, A., Hewitt, C. J., Nienow, A. W., Verter, F., & Rafiq, Q. A. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107636 · Cited by 86
Zhang, M., Wang, L., Huang, S., & He, X. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-020-09950-0 · Cited by 87
Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies
Báez-Jurado, E., Hidalgo‐Lanussa, O., Barrera-Bailón, B., Sahebkar, A., Ashraf, G. M., Echeverría, V., & Barreto, G. E. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1570-x · Cited by 87
Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies
Fraile, M., Eiró, N., Costa, L. A., Martín, A., & Vizoso, F. J. (2022) · Biology · doi:10.3390/biology11111678 · Cited by 92
“This might be due to the inhibition of MMPs, which is related with the loss of invasiveness of cancer cells.”
BackgroundSelf-citationHu, C., Zhao, L., Duan, J., & Li, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14115 · Cited by 77
“The secretome is a special set of factors (soluble proteins, free nucleic acids, lipids and extracellular vesicles) secreted into the extracellular space and changes in response to fluctuations in various conditions.(42) Cell‐free secretome isolated from MSCs exerted antifibrotic effects by inhibiting activation of TG…”
BackgroundCell therapy for orofacial bone regeneration: A systematic review and meta‐analysis
Shanbhag, S., Suliman, S., Pandis, N., Stavropoulos, A., Sanz, M., & Mustafa, K. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13049 · Cited by 86
Bellei, B., Migliano, E., TEDESCO, M., Caputo, S., Papaccio, F., Lopez, G., & Picardo, M. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0956-4 · Cited by 79
Clinical Potential of Mesenchymal Stem Cell-Derived Exosomes in Bone Regeneration
Torrecillas-Baena, B., Pulido-Escribano, V., Dorado, G., Gálvez-Moreno, M. Á., Camacho-Cardeñosa, M., & Casado‐Díaz, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134385 · Cited by 81
Biological Considerations in Scaling Up Therapeutic Cell Manufacturing
Cherian, D. S., Bhuvan, T., Meagher, L., & Heng, T. S. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00654 · Cited by 82
The Potential of Bovine Colostrum-Derived Exosomes to Repair Aged and Damaged Skin Cells
Han, G., Kim, H., Kim, D. E., Ahn, Y., Kim, J., Jang, Y. J., Kim, K., Yang, Y., & Kim, S. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020307 · Cited by 80
“Due to these characteristics, stem cell-derived exosomes are widely used as materials for regenerative medicine [18,19].”
BackgroundNovel approaches using mesenchymal stem cells for curing peripheral nerve injuries
Yousefi, F., Arab, F. L., Nikkhah, K., Amiri, H., & Mahmoudi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.052 · Cited by 75
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
d’Angelo, M., Cimini, A., & Castelli, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155241 · Cited by 73
Chen, S., Chen, Z., Lin, Y.-H., Chen, S.-H., Chou, P., Kao, H., & Lin, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212373 · Cited by 72
Conditioned media-integrated microneedles for hair regeneration through perifollicular angiogenesis
Yuan, A., Gu, Y., Bian, Q., Wang, R., Xu, Y., Ma, X., Zhou, Y., & Gao, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.007 · Cited by 72
Kim, J., Lee, C., Shin, Y., Wang, S., Han, J., Kim, M., Kim, J. M., Shin, S.-C., Lee, B.-J., Kim, T.-J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.025 · Cited by 69
“Growing evidence indicates that the therapeutic effects of MSC therapy are mediated by secretory factors that MSCs produce and release, and these secretory factors are called the MSC secretome.(34) Because sEVs are a part of the MSC secretome, it has been reported that sEVs released from MSCs are highly involved in th…”
BackgroundFernández-Francos, S., Eiro, N., González-Galiano, N., & Vizoso, F. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157850 · Cited by 68
“After many decades of research, MSC were found in the stroma of other locations, such as adipose tissue (AT), umbilical cord (UC), Wharton’s jelly (WJ), uterus, placenta, amniotic fluid, lung, cartilage synovial fluid or membrane, tonsil, dermis, skeletal muscle, periosteum, periodontal ligament dental pulp or periphe…”
BackgroundInfluentialSelf-citationGonzalez‐Pujana, A., Vining, K. H., Zhang, D. K. Y., Santos‐Vizcaíno, E., Igartúa, M., Hernández, R. M., & Mooney, D. J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120266 · Cited by 72
Delivery of cellular factors to regulate bone healing
Haumer, A., Bourgine, P. E., Occhetta, P., Born, G., Tasso, R., & Martín, I. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.010 · Cited by 72
Low dose of extracellular vesicles identified that promote recovery after ischemic stroke
Otero-Ortega, L., Laso-García, F., Frutos, M. C. G.-D., Diekhorst, L., Martínez-Arroyo, A., Alonso-López, E., García-Bermejo, M. L., Rodríguez-Serrano, M., Arrúe-Gonzalo, M., Díez-Tejedor, E., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01601-1 · Cited by 66
Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
Gugliandolo, A., Bramanti, P., & Mazzon, E. (2019) · Stem Cells International · doi:10.1155/2019/3675627 · Cited by 76
“The biomolecules included in secretome derivatives, such as conditioned medium (CM) or exosomes, may promote tissue repair and mediated immunomodulation, anti-inflammatory, and antiapoptotic activities [32].”
Application of adipose-derived stem cells in photoaging: basic science and literature review
Chen, S., He, Z., & Xu, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01994-z · Cited by 77
Liu, M., Zhang, D., Zhou, X., Duan, J., Hu, Y., Zhang, W., Liu, Q., Xu, B., & Zhang, A. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03012-w · Cited by 70
“Recently, with the development of regenerative medicine, stem cell therapy has been studied for the treatment of POI [9].”
BackgroundJalilian, E., Massoumi, H., Bigit, B., Amin, S., Katz, E. A., Guaiquil, V. H., Anwar, K. N., Hematti, P., Rosenblatt, M. I., & Djalilian, A. R. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03128-z · Cited by 69
Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
Chen, Z., Chen, L., Zeng, C., & Wang, W. E. (2018) · Stem Cells International · doi:10.1155/2018/7045245 · Cited by 66
“Stem cell candidates mainly include two categories: (1) pluripotent stem cells (embryonic stem cell and induced pluripotent stem cells) and their derivatives and (2) adult stem cells, including hematopoietic stem cells and mesenchymal stem cells (MSCs) [5].”
BackgroundMethodInfluentialTargeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment
Lee, J., Kyung, J. W., Kumar, H., Kwon, S. P., Song, S. Y., Han, I.-B., & Kim, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114185 · Cited by 68
“Recent studies have revealed that the therapeutic effects of MSCs are mainly attributed to exosomes, which are a type of extracellular vesicles that contain RNAs and proteins and serve as a nanocarrier of the biomolecules between cells [14,15].”
BackgroundPark, H.-S., Chugh, R. M., Seok, J., Cetin, E. C., Mohammed, H., Siblini, H., Ali, F. L., Ghasroldasht, M. M., Alkelani, H., Elsharoud, A., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03397-2 · Cited by 65
Therapeutic Applications of Stem Cell-Derived Exosomes
Abdulmalek, O. A. A. Y., Husain, K. H., AlKhalifa, H. K. A. A., Alturani, M. M. A. B., Butler, A. E., & Moin, A. S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063562 · Cited by 75
“The internalization of these biomolecules into the aforementioned recipient cells is facilitated by the many membrane-bound molecules found on the lipid bilayers of these exosomes, making this an essential property of these vesicles [17].”
BackgroundThe Delivery of Extracellular Vesicles Loaded in Biomaterial Scaffolds for Bone Regeneration
Yan, H., Yu, T., Li, J., Qiao, Y., Wang, L., Zhang, T., Li, Q., Zhou, Y.-H., & Liu, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.01015 · Cited by 72
Kuppa, S. S., Kim, H. K., Kang, J. Y., Lee, S. C., & Seon, J. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113016 · Cited by 67
Chen, T.-F., Chen, K.-W., Chien, Y., Lai, Y., Hsieh, S., Ma, H.-Y., Wang, K., & Shiau, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153747 · Cited by 73
“However, since implanted MSCs do not survive for long, it is widely believed that the bioactive factors produced by MSCs exert beneficial therapeutic effect and contribute to the MSC-mediated beneficial effects in synergism [13,14].”
BackgroundResearch Progress on Stem Cell Therapies for Articular Cartilage Regeneration
Jiang, S., Tian, G., Li, X., Yang, Z., Wang, F., Tian, Z., Huang, B., Fu, W. E., Zha, K., Sun, Z., et al. (2021) · Stem Cells International · doi:10.1155/2021/8882505 · Cited by 72
“Stem cell derivatives are an extension of the paracrine theory of stem cells (Figure 1), in which the secretome is considered to be the mechanism through which stem cells exert their tissue repair and regeneration effects [132].”
BackgroundChen, W.-C., Liu, W.-F., Bai, Y., Zhou, Y., Zhang, Y., Wang, C., Lin, S., & He, H. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02843-0 · Cited by 67
“Furthermore, as a neuroprotective role, MSCs secrete many neurotrophic factors, such as brain-derived growth factor (BDNF), glial-derived growth factor (GDNF), nerve growth factor (NGF), NT-1, NT-3, and basic fibroblast growth factor (bFGF) [10, 35].”
BackgroundRahimi, B., Panahi, M., Saraygord‐Afshari, N., Taheri, N., Bilici, M., Jafari, D., & Alizadeh, E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06360-7 · Cited by 66
Nitkin, C. R., Rajasingh, J., Pisano, C., Besner, G. E., Thébaud, B., & Sampath, V. (2019) · Pediatric Research · doi:10.1038/s41390-019-0425-5 · Cited by 69
Chen, C., Chen, Y., Li, M., Xiao, H., Shi, Q., Zhang, T., Li, X., Zhao, C., Hu, J., & Lü, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119996 · Cited by 62
Microfluidic-Based Droplets for Advanced Regenerative Medicine: Current Challenges and Future Trends
Nazari, H., Heirani‐Tabasi, A., Ghorbani, S., Eyni, H., Bazaz, S. R., Khayati, M., Gheidari, F., Moradpour, K., Kehtari, M., Tafti, S. M. A., et al. (2021) · Biosensors · doi:10.3390/bios12010020 · Cited by 63
“Recent studies show that the regeneration caused by stem cells is mainly caused by secretome proteins, exosomes, and EVs generated by transplanted stem cells [145].”
BackgroundEiró, N., Fraile, M., González-Jubete, A., González, L. O., & Vizoso, F. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168905 · Cited by 66
“Therefore, MSC secretome may be considered a new therapeutic product [253] which can avoid some concerns derived from the use of stem cells themselves and offers several advantages: (i) easier to handle in the clinical practice; (ii) easier evaluation of safety, dose, and potency; (iii) storage without toxic cryoprese…”
BackgroundInfluentialSelf-citationAging and homeostasis of the hypodermis in the age-related deterioration of skin function
Liu, M., Lu, F., & Feng, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06818-z · Cited by 79
“ASC-MVs are perceived as mediators of intercellular communication and can be engulfed by human umbilical vein endothelial cells (HUVECs), HaCAT, and fi broblasts, along with all types of primary skin cells [163].”
BackgroundKumar, A., Kumar, V., Rattan, V., Jha, V., & Bhattacharyya, S. (2018) · Biochimie · doi:10.1016/j.biochi.2018.10.014 · Cited by 62
“as well as soluble growth factors and small peptides (13-16).”
BackgroundYao, M., Li, J., Zhang, J., Ma, S., Wang, L., Gao, F., & Guan, F. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02033h · Cited by 60
Trivedi, A. A., Miyazawa, B. Y., Gibb, S. L., Valanoski, K., Vivona, L. R., Lin, M., Potter, D. R., Stone, M., Norris, P. J., Murphy, J., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1877-4 · Cited by 61
Tissue Engineering and Regenerative Medicine 2017: A Year in Review
Park, K. M., Shin, Y. M., Kim, K., & Shin, H. (2018) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2018.0027 · Cited by 64
“106 A variety of stem cells may be excellent cellular sources of therapeutic exosomes, and clinical utilization of these bioactive signaling mediators could facilitate tissue repair strategies, specifically the bench-to-bedside development of cell-free medial therapies.”
Liu, X., Li, X., Wu, G., Qi, P., Zhang, Y., Liu, Z., Li, X., Yu, Y., Ye, X., Li, Y., et al. (2022) · Stem Cells International · doi:10.1155/2022/1252557 · Cited by 72
“Moreover, MSC-derived have many advantages over MSCs, such as less safety concerns [28], long-term preservation and easy transportation [29], lower immunogenicity [30], and capacity to cross biological barriers [31].”
BackgroundThe role of MSCs and CAR-MSCs in cellular immunotherapy
Yan, L., Li, J., & Zhang, C. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01191-4 · Cited by 63
Mesenchymal stem cell dysfunction in diabetes
Fijany, A. J., Sayadi, L. R., Khoshab, N., Banyard, D. A., Shaterian, A., Alexander, M., Lakey, J. R. T., Paydar, K. Z., Evans, G. R. D., & Widgerow, A. D. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4516-x · Cited by 64
“Previous studies have focused on the capacity for stem cells to differentiate into diverse cell types, however recent evidence suggests that the therapeutic effects of stem cells are a result of their secreted factors [116].”
BackgroundHuang, F., Gao, T., Wang, W., Wang, L., Xie, Y., Tai, C., Liu, S., Cui, Y., & Wang, B. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02537-w · Cited by 60
“For example, MSCs release a large number of anti-inflammatory factors, cytokines, growth factors, and cell adhesion factors to change the microenvironment of SCI [30, 31].”
BackgroundOh, S., Seo, S. B., Kim, G., Batsukh, S., Park, C., Son, K. H., & Byun, K. (2023) · Antioxidants · doi:10.3390/antiox12061204 · Cited by 59
“ASCs exhibit paracrine effects by secreting various cytokines, active substances, and exosomes [18,19].”
BackgroundRong, X., Li, J., Yang, Y., Shi, L., & Jiang, T. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1456-x · Cited by 57
RetractedEnhancement strategies for mesenchymal stem cells and related therapies
Alagesan, S., Brady, J., Byrnes, D., Fandiño, J., Masterson, C. H., McCarthy, S., Laffey, J. G., & O’Toole, D. P. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02747-w · Cited by 57
“There is an abundance of evidence to suggest that the composition of EVs in the MSC secretome is largely influenced by the environment to which the MSCs are exposed [111, 121].”
BackgroundFathi-Kazerooni, M., Ghazi, S. F., Darzi, M., Makarem, J., Nasiri, R., Salahshour, F., Manshadi, S. A. D., & Kazemnejad, S. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02771-w · Cited by 60
Lee, C.-S., Fan, J., Hwang, H. S., Kim, S., Chen, C., Kang, M., Aghaloo, T. L., James, A. W., & Lee, M. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04159 · Cited by 57
Extracellular vesicles: Potential role in osteoarthritis regenerative medicine
Wu, X., Wang, Y., Xiao, Y., Crawford, R., Mao, X., & Prasadam, I. (2019) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2019.10.012 · Cited by 63
“MSCs can be divided into three types: embryonic stem cells, pluripotent stem cells, and adult stem cells [16].”
BackgroundGugliandolo, A., & Mazzon, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010456 · Cited by 61
“Moreover, secretome production is more economical and mass production under controlled laboratory conditions is also possible [107].”
BackgroundStrategies of cell and cell-free therapies for periodontal regeneration: the state of the art
Wang, X., Chen, J., & Tian, W. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03225-z · Cited by 69
“MSCs-CM [61] contains anti-inflammatory TGF-β1, IL-10, IL-12, IL17E, IL-27, and proinflammatory cytokines, such as IL-1b, IL-6, IL-8, and IL-9.”
BackgroundMaiti, P., Peruzzaro, S., Kolli, N., Andrews, M., Gharaibeh, A., Rossignol, J., & Dunbar, G. L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14396 · Cited by 58
Kamat, P., Frueh, F. S., McLuckie, M., Sanchez‐Macedo, N., Wolint, P., Lindenblatt, N., Plock, J. A., Calcagni, M., & Buschmann, J. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.03.433 · Cited by 60
Camões, S. P., Bulut, O., Yazar, V., Gaspar, M. M., Simões, S., Ferreira, R., Vitorino, R., Santos, J. M., Gursel, I., & Miranda, J. P. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.01.013 · Cited by 55
“Moreover, as changes in cell environment admittedly influence the cell responses including exosome secretion [54], we first evaluated the impact of the different culture conditions on the cargo of the UC-MSC exosomes and its effect in wound healing.”
BackgroundStem Cell Aging in Lifespan and Disease: A State-of-the-Art Review
Sameri, S., Samadi, P., Dehghan, R., Salem, E., Hosseini, N. F., & Amini, R. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200213105155 · Cited by 58
Basalova, N. A., Mikhail, A., Vladimir, P., Olga, G., Maksim, V., Ivan, Z., Novoseletskaya, E. S., Sagaradze, G. D., Natalia, D., Pavel, M., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01017-w · Cited by 58
Zhang, C., Wang, T., Zhang, L., Chen, P., Tang, S., Chen, A., Li, M., Peng, G., Gao, H., Weng, H., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02061-3 · Cited by 55
“Mainly, adipose-derived stem cells conditioned medium (ADSC-CM) derives signi cant bene ts from the advantages of easy access, convenient utility, and high security [6], which may seem an outperformer in stem cell therapy.”
BackgroundTherapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS
Park, H.-S., Cetin, E. C., Siblini, H., Seok, J., Alkelani, H., Alkhrait, S., Ali, F. L., Ghasroldasht, M. M., Beckman, A., & Al-Hendy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311151 · Cited by 56
“, conditioned media) in various diseases, including neurological disorders [20], cardiac ischemia [21], diabetes [22], bone and cartilage diseases [23], liver injury or fibrosis [24], spinal cord injury, and wound healing [25].”
BackgroundKwon, S. C., Yoo, K. H., Sym, S. J., & Khang, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s217923 · Cited by 57
“challenging due to poor protein stability, pharmacokinetics, and tissue transport.(179,180)”
BackgroundThe Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes
Gavin, C., Meinke, S., Heldring, N., Heck, K. A., Achour, A., Iacobaeus, E., Höglund, P., Blanc, K. L., & Kadri, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02249 · Cited by 61
“Their immune-modulatory function has mainly been ascribed to paracrine mechanisms associated with secretion of immunoregulatory mediators including cytokines and growth factors which modulate inflammatory response and balance immune profiles (2).”
Massa, M., Croce, S., Campanelli, R., Abbà, C., Lenta, E., Valsecchi, C., & Avanzini, M. A. (2020) · Diagnostics · doi:10.3390/diagnostics10120999 · Cited by 57
“MSC-EVs may significantly decrease the cell death in inflamed tissue by lowering the gene expression of pro-apoptotic Bax and increasing the expression of anti-apoptotic Bcl-2 [25].”
BackgroundJi, W., Jiang, W.-T., Li, M., Li, J., & Li, Z. (2019) · Biochimie · doi:10.1016/j.biochi.2019.10.002 · Cited by 58
Tan, L., Cao, Z., Chen, H., Xie, Y., Yu, L., Fu, C., Zhao, W., & Wang, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119125 · Cited by 57
Shi, L., Ren, J., Li, J., Wang, D., Wang, Y., Qin, T., Li, X., Zhang, G., Li, C., & Wang, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02296-8 · Cited by 56
“Furthermore, application of the EVs as a cell-free therapy provides crucial advantages over stem cell therapies [39], (1) can avoid many risks associated with the transplantation of”
BackgroundSharma, S., Muthu, S., Jeyaraman, M., Ranjan, R., & Jha, S. K. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1360 · Cited by 56
Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges
Taei, A. A., Khodabakhsh, P., Nasoohi, S., Farahmandfar, M., & Dargahi, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02967-4 · Cited by 58
“The MSCs participate in cell survival by upregulating anti-apoptotic proteins and downregulating pro-apoptotic proteins [51, 71].”
BackgroundInfluentialMesenchymal Stromal Cells as a Driver of Inflammaging
Lyamina, S., Baranovskii, D., Kozhevnikova, E., Иванова, Т. Б., Валерьевич, К. С., Sadekov, T. S., Klabukov, I., Maev, I. V., & Govorun, V. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076372 · Cited by 62
“Thus, we can expect a novel cell-free product based on the secretome of immortalized primary-like human MSCs lines from different tissues with subsequently predicted activities [117].”
BackgroundMiceli, V., Zito, G., Bulati, M., Gallo, A., Busà, R., Iannolo, G., & Conaldi, P. G. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i5.400 · Cited by 57
Sávio-Silva, C., Beyerstedt, S., Soinski-Sousa, P. E., Casaro, E. B., Balby-Rocha, M. T. A., Simplício-Filho, A., Alves-Silva, J., & Rangel, É. B. (2020) · Stem Cells International · doi:10.1155/2020/8833725 · Cited by 57
“MSC-derived secretome is a cell-free alternative for treating DM1 and DM2 individuals, which can bypass some issues related to autologous and allogeneic MSCs [186].”
BackgroundYang, Y., & Zhang, H. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401547 · Cited by 67
Signaling pathways activated and regulated by stem cell-derived exosome therapy
Li, D., Li, D., Wang, Z., Li, J., Shahzad, K. A., Wang, Y., & Tan, F. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01277-7 · Cited by 57
Immunomodulatory Properties of Mesenchymal Stromal Cells: Still Unresolved “Yin and Yang”
Poggi, A. D., & Zocchi, M. R. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x14666181205115452 · Cited by 54
Potential of Exosomes as Cell-Free Therapy in Articular Cartilage Regeneration: A Review
Ng, C. Y., Chai, J. Y., Foo, J. B., Yahaya, N. H. M., Yang, Y., Ng, M. H., & Law, J. X. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s327059 · Cited by 57
Role of adipose mesenchymal stem cells and secretome in peripheral nerve regeneration
Sumarwoto, T., Suroto, H., Mahyudin, F., Utomo, D. N., Romaniyanto, Tinduh, D., Notobroto, H. B., Prakoeswa, C. R. S., Rantam, F. A., & Rhatomy, S. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102482 · Cited by 59
“7 of the myelin sheath, modulation of the stage of Wallerian degeneration, accelerated regeneration of nerve fibers and increased number of nerve fibers, decreased scar fibrosis, and increased nerve fiber organization [53].”
BackgroundMethodInfluential
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.